mayoly spindler committed to your health. every day. · our assets a french company three...
Post on 06-Nov-2020
1 Views
Preview:
TRANSCRIPT
MAYOLY SPINDLER
Committed to your health.
Every day.
2
OUR AMBITION
Become an
international reference
in gastroenterology
and dermo-cosmetics
CONTENTS
OUR ASSETS
A French company
An independent company
An extensive global footprint
25/06/2018PRESENTATION EXCLUSIVELY
FOR OFFICIAL BODIES
3
OUR EMPLOYEES’
COMMITMENT
Our values
A responsible company
OUR FIELDS OF
EXPERTISE
Pharmaceuticals
Dermo-cosmetics
Contract Development &
Manufacturing
OUR ASSETSa French company
▪ Three manufacturing facilities near Paris, 1 in Chatou
(West of Paris) and 2 in Dammarie-les-Lys (East of Paris).
▪ Over 880 employees worldwide, including nearly 610 in
France.
▪ Turnover: €190 million in 2017.
▪ 70% of products sold are made in France.
▪ An economic player contributing to France’s status as one
of the world’s leading pharmaceuticals exporters*.
425/06/2018
PRESENTATION EXCLUSIVELY
FOR OFFICIAL BODIES
* Source: LEEM (French Pharmaceutical Companies Association)– Economic report, 2016 issue.
OUR ASSETSan independent company
▪ Founded in 1909: for more than a century, an
entrepreneurial adventure.
▪ Still an entirely family-owned company.
▪ Financial independence, a main performance driver.
▪ Uninterrupted growth laying the foundations for the
company’s long-term development.
525/06/2018
PRESENTATION EXCLUSIVELY
FOR OFFICIAL BODIES
126138
145154 159 161
167 173
190
0
20
40
60
80
100
120
140
160
180
200
2009 2010 2011 2012 2013 2014 2015 2016 2017
NET CONSOLIDATED TURNOVER
2009-2017 (€ million)
OUR ASSETSan extensive global footprint
▪ Established worldwide in more than 70 countries generating
45% of overall turnover (vs France 55%)
▪ Dynamic subsidiaries: in Europe, Eastern Europe, Asia and
Latin America (32% of international turnover in 2017)
▪ Business partners committed for the long term
▪ A proactive development policy
▪ With the acquisition in 2016 of Kibion, a Swedish company
principally operating in Germany and the Middle East,
Mayoly Spindler has become one of the world leaders in the
detection and control of Helicobacter pylori infections.
25/06/2018PRESENTATION EXCLUSIVELY
FOR OFFICIAL BODIES
6
Subsidiaries
Distributors
OUR FIELDS OF
EXPERTISE
7
PHARMACEUTICALS
8
PHARMACEUTICALSOur historical pillar of development
▪ Pharmaceutical sector: 80% of overall turnover in 2017
▪ Gastroenterology: 70% of our pharmaceutical business.
▪ A portfolio of therapeutic solutions spanning speciality
care, primary care and self-medication.
▪ An investment in collaborative R&D in gastroenterology.
925/06/2018
PRESENTATION EXCLUSIVELY
FOR OFFICIAL BODIES
Pharmaceuticals
€154 million
Dermo-cosmetics
€23 million
CDMO *
€13 million
13 %
7 %
80 %
* Contract Development & Manufacturing Organization
BREAKDOWN OF TURNOVER
BY BUSINESS SECTOR IN 2017
OUR GE THERAPEUTIC SOLUTIONS PORTFOLIO
1025/06/2018
PRESENTATION EXCLUSIVELY
FOR OFFICIAL BODIES
10
Travel sickness
Digestive and renal
elimination functions
Colonoscopy
Pancreatic insufficiency
Cystic fibrosis
Acid reflux
Abdominal pains Crohn’s disease
Constipation
Heartburn
Diagnostic tests
Probiotics / Gut flora
Biliary lithiasis
Biliary cirrhosis
Gaz
DERMO-COSMETICS
11
DERMOCOSMETICSTopicrem, the science of hydration
▪ Ultra-Moisturizing Body Milk
is the n°1 body moisturizer in France*.
▪ High-quality manufacturing standards recognized on an
international level.
▪ All worldwide production of Topicrem is made in France (Dammarie-Les-Lys).
▪ An international brand (50% of Topicrem sales generated
outside of France).
1225/06/2018
PRESENTATION EXCLUSIVELY
FOR OFFICIAL BODIES
* France IMS data Décembre 2016.
BREAKDOWN OF TURNOVER
BY BUSINESS SECTOR IN 2017
Pharmaceuticals
€154 million
Dermo cosmetics
€23 million CDMO *
€13 million
13 % 7 %
80 %
* Contract Development & Manufacturing Organization
PRODUCTION &
CONTRACT
MANUFACTURING
13
PRODUCTION & CONTRACT MANUFACTURINGTechnical prowess and responsiveness
▪ An agile structure offering our customers a wide range of
possibilities that meet their requirements in pharmaceuticals,
nutraceuticals and dermo-cosmetics
▪ A diversified offer: softgel capsules, tablets, capsules,
syrups, creams…
▪ A softgel capsules expertise requiring a particular
technicality.
▪ They trust us:
25/06/2018PRESENTATION EXCLUSIVELY
FOR OFFICIAL BODIES
BREAKDOWN OF TURNOVER
BY BUSINESS SECTOR IN 2017
14
Pharmaceuticals
€154 million
Dermo cosmetics
€23 million
CDMO *
€13 million
13 %
7 %
80 %
* Contract Development & Manufacturing Organization
OUR EMPLOYEES’
COMMITMENT,
CENTRAL TO OUR
SUCCESS
15
OUR VALUES
25/06/2018PRESENTATION EXCLUSIVELY
FOR OFFICIAL BODIES
16
Our performance is the result of the talent of our employees who, every day, share ambitious projects and a test for challenge.
Our corporate culture is reflected in the empowerment of our teams, the opportunity to take initiatives and the pragmatism of each individual.
Mayoly Spindler is a company where respect goes hand-in-hand with growth, fostering the well-being of everyone.
RESPONSIBILITY RESPECT PRAGMATISM
A RESPONSIBLE COMPANY
▪ OUR MAYOLY, our corporate responsibility programme.
▪ Three priorities: workplace well-being, commitment to the
community and care for the environment.
▪ Projects designed and coordinated by employees,
working in the general interest.
25/06/2018PRESENTATION EXCLUSIVELY
FOR OFFICIAL BODIES
17
MAYOLY
SPINDLER
AT A GLANCE
18
45%of turnover generated
outside of France.
19
3 production sitesnear Paris: 1 in Chatou
and 2 in Dammarie-les-lys
€190 million turnoverPharmaceuticals: 80%
Dermo-cosmetics: 13%
Production: 7%
Over 880employees worldwide,
including 610 in France.
Figures as at 31/12/2017.
Committed to your health.
Every day.
top related